STRONGBRIDGE BIOPHARMA plc Share-based Payment Arrangement, Expense
STRONGBRIDGE BIOPHARMA plc reported Share-based Payment Arrangement, Expense of $2.08 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for the quarter ending 2021-06-30 was $2.08M, a 17.43% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for the quarter ending 2021-03-31 was $2.28M, a 30.04% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for the quarter ending 2020-12-31 was $1.79M, a 17.03% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for the quarter ending 2020-09-30 was $2.07M, a 4.83% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for fiscal 2020 was $7.38M, a 14.14% decline from fiscal 2019.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for fiscal 2019 was $8.60M, a 10.12% increase from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for fiscal 2018 was $7.81M, a 51.09% increase from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc share-based payment arrangement, expense for fiscal 2017 was $5.17M, a 12.18% increase from fiscal 2016.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | $2.08M 10-Q · filed 2021-08-05 | $4.36M 10-Q · filed 2021-08-05 | $6.15M derived: sum of 3 quarters · filed 2021-08-05 | $8.22M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $2.28M 10-Q · filed 2021-05-12 | $4.06M derived: sum of 2 quarters · filed 2021-05-12 | $6.13M derived: sum of 3 quarters · filed 2021-05-12 | $7.91M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $3.86M derived: sum of 2 quarters · filed 2021-03-03 | $5.63M derived: sum of 3 quarters · filed 2021-08-05 | $7.38M 10-K · filed 2021-03-03 |
| 2020-09-30 | $2.07M 10-Q · filed 2020-10-29 | $3.84M derived: sum of 2 quarters · filed 2021-08-05 | $5.59M 10-Q · filed 2020-10-29 | $7.12M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $1.77M 10-Q · filed 2021-08-05 | $3.52M 10-Q · filed 2021-08-05 | $5.05M derived: sum of 3 quarters · filed 2021-08-05 | $7.23M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.75M 10-Q · filed 2021-05-12 | $3.28M derived: sum of 2 quarters · filed 2021-05-12 | $5.45M derived: sum of 3 quarters · filed 2021-05-12 | $8.03M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $3.70M derived: sum of 2 quarters · filed 2021-03-03 | $6.27M derived: sum of 3 quarters · filed 2021-03-03 | $8.60M 10-K · filed 2021-03-03 |
| 2019-09-30 | $2.17M 10-Q · filed 2020-10-29 | $4.75M derived: sum of 2 quarters · filed 2020-10-29 | $7.07M 10-Q · filed 2020-10-29 | $9.09M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | $2.57M 10-Q · filed 2020-08-04 | $4.89M 10-Q · filed 2020-08-04 | $6.91M derived: sum of 3 quarters · filed 2021-03-03 | $9.03M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | $2.32M 10-Q · filed 2020-05-06 | $4.34M derived: sum of 2 quarters · filed 2021-03-03 | $6.46M derived: sum of 3 quarters · filed 2021-03-03 | $8.44M derived: sum of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $4.13M derived: sum of 2 quarters · filed 2021-03-03 | $6.12M derived: sum of 3 quarters · filed 2021-03-03 | $7.81M 10-K · filed 2021-03-03 |
| 2018-09-30 | $2.12M 10-Q · filed 2019-11-07 | $4.10M derived: sum of 2 quarters · filed 2019-11-07 | $5.79M 10-Q · filed 2019-11-07 | $7.09M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $1.99M 10-Q · filed 2019-07-31 | $3.67M 10-Q · filed 2019-07-31 | $4.98M derived: sum of 3 quarters · filed 2020-02-28 | $6.31M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $1.69M 10-Q · filed 2019-05-01 | $2.99M derived: sum of 2 quarters · filed 2020-02-28 | $4.32M derived: sum of 3 quarters · filed 2020-02-28 | $5.68M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.63M derived: sum of 2 quarters · filed 2020-02-28 | $4.00M derived: sum of 3 quarters · filed 2020-02-28 | $5.17M 10-K · filed 2020-02-28 |
| 2017-09-30 | $1.33M 10-Q · filed 2018-10-31 | $2.69M derived: sum of 2 quarters · filed 2018-10-31 | $3.86M 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $1.36M 10-Q · filed 2018-08-08 | $2.53M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $1.17M 6-K · filed 2017-05-16 | |||
| 2016-12-31 | $4.61M 10-K · filed 2019-02-27 | |||
| 2016-06-30 | $1.09M 6-K · filed 2017-08-07 | $2.42M 6-K · filed 2017-08-07 | ||
| 2016-03-31 | $1.33M 6-K · filed 2017-05-16 | |||
| 2015-12-31 | $3.94M 10-K · filed 2018-03-12 |